Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-029040

Director sold 12,195 shares at an average $50.88 ($620,443)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Fust Matthew K · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-07 Sale : show line 1 in the form 10b5-1 −2,550 $50.89 $129,770 24,505 D
2024-03-07 Sale : show line 2 in the form 10b5-1 −2,145 $50.85 $109,073 22,360 D
2024-03-07 Sale : show line 3 in the form 10b5-1 −7,500 $50.88 $381,600 14,860 D
Open-market sales · 12,195 sh · avg $50.88 · $620,443
Loading xslF345X05/ownership.xml…